If you take a prescription antidepressant and need to undergo drug testing, you may wonder whether the medication could affect your results.
Most routine drug screens are not designed to detect antidepressants themselves. However, some medications may interfere with particular screening assays and produce an unexpected or presumptive positive result for another drug class. Whether this occurs depends on the medication, the assay, the specimen and the substances being tested.
For this reason, an unexpected screening result should be interpreted in the context of the testing method and, where appropriate, followed by more specific laboratory analysis.
Are Antidepressants Included in Standard Drug Tests?
Drug tests are designed to detect specific substances or drug classes included in the testing panel. There is no single drug test that detects every medication or controlled substance.
Many routine drug screens target drug classes such as:
- Amphetamines
- Cocaine
- Cannabinoids
- Opioids
- Phencyclidine (PCP)
The exact panel can vary depending on why the testing is being performed and which substances need to be investigated. Drug test panels may include different combinations of substances depending on the testing requirements.
Most antidepressants are not primary targets of these routine panels. However, that does not mean an antidepressant can never be relevant to a drug-testing result.
Certain medications have been associated with cross-reactivity in particular immunoassay screening methods. This can sometimes produce a presumptive positive for a drug that the individual has not taken.
Can Antidepressants Cause a False Positive Drug Test?
Some antidepressants have been reported to produce unexpected results on certain drug-screening assays.
Many initial drug screens use immunoassay technology. These tests are useful for rapidly screening samples, but the antibodies used by an assay can sometimes react with compounds other than the substance the test is intended to identify.
This is known as cross-reactivity.
As a result, an initial positive screening result does not necessarily establish that the specific drug being screened for is present.
The possibility of cross-reactivity depends on several factors, including:
- The medication being taken
- Its metabolites
- The drug class being screened
- The specific assay being used
- The concentration of compounds in the specimen
- The specimen type
This is why a medication history can be important when an unexpected screening result is being investigated.
Which Antidepressants Can Affect Drug Test Results?
The possibility of an unexpected drug-screening result varies between medications and testing methods. Certain antidepressants may be associated with cross-reactivity in particular screening assays, potentially producing an unexpected or presumptive positive result.
This does not mean that taking an antidepressant will automatically result in a positive drug test.
A medication may interact with one screening assay but not another. The result also depends on what the assay is designed to detect and how the sample is analysed.
For this reason, it is more accurate to consider the potential for assay interference rather than assume that a particular antidepressant will always cause a false positive.
Do Tricyclic Antidepressants Show Up on Drug Tests?
Tricyclic antidepressants (TCAs) are a class of medications that can be specifically relevant to toxicology testing.
Some testing panels are designed to detect TCAs, while other routine drug screens do not include them. Whether a TCA is included depends on the purpose of the test and the substances the laboratory has been asked to investigate.
Examples of TCAs include:
- Amitriptyline
- Nortriptyline
- Imipramine
- Doxepin
- Desipramine
When there is a specific reason to investigate TCA exposure, tricyclic antidepressant testing can provide targeted information beyond what a routine drug screen is designed to detect.
What is the Difference Between Screening and Confirmatory Testing?
One of the most important distinctions in drug testing is the difference between an initial screen and confirmatory laboratory testing.
Initial drug screening
Screening methods are often used to identify samples that may contain a substance or drug class of interest.
Immunoassay screening can be useful for processing samples efficiently, but a presumptive positive does not necessarily provide definitive identification of a specific substance.
Confirmatory testing
Confirmatory analysis uses more specific analytical techniques to establish whether a particular substance or metabolite is present.
Depending on the testing requirements, techniques such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS/MS) may be used for more specific identification.
The distinction can be particularly important when a result has potential legal, employment, medical or other significant implications.
What Medications Show Up on a Drug Test?
A drug test only detects substances that fall within the scope of the testing method and panel being used.
This means there is no universal list of medications that will “show up” on every drug test.
A routine drug screen may target particular drug classes, while a targeted toxicology analysis can be designed to investigate specific medications, drugs, metabolites or other substances.
The type of specimen can also affect what a laboratory can investigate. Depending on the circumstances, testing may involve specimens such as urine, blood or hair.
The important question is therefore not simply whether a medication can show up on a drug test, but what the particular test is designed to detect and what analytical method is being used.
How Long Can Antidepressants Be Detected?
There is no single detection window that applies to every antidepressant.
The period during which a substance or metabolite may be detectable can vary according to:
- The specific medication
- Dose and frequency of use
- Individual metabolism
- Specimen type
- Time since exposure
- The analytical method
- The sensitivity of the test
- The substance or metabolite being investigated
Urine, blood and hair can provide different information about exposure, so detection should always be considered in relation to the specimen and testing method.
For that reason, it is not appropriate to give one universal detection period for all antidepressants.
What Happens After an Unexpected Drug-Test Result?
An unexpected initial drug-screening result does not necessarily mean that the person has taken the drug identified by the screen.
If an individual is taking prescription or over-the-counter medications, providing an accurate medication history can help put the result into context.
Depending on the circumstances, the next step may involve more specific laboratory analysis to determine whether the substance identified by the initial screen is actually present.
This distinction is particularly important when drug-test results are being used for forensic, employment, legal or other high-stakes purposes.
Why is Confirmatory Testing Important?
The purpose of confirmatory testing is to provide a more specific analytical assessment of a sample.
Rather than relying solely on the response of an initial screening assay, confirmatory methods can be used to identify a particular substance or metabolite with greater analytical specificity.
In forensic toxicology, this distinction can be important because laboratory findings may form part of a broader investigation. The result needs to be interpreted in the context of the specimen, analytical method, testing circumstances and other available information.
Understanding Antidepressants and Drug Testing
Whether an antidepressant affects a drug-test result depends on what is being tested, how the sample is analysed and which substances the particular assay is designed to detect.
Most routine drug screens do not target antidepressants. However, some medications may interfere with particular screening methods, and an unexpected presumptive result may require further investigation.
For tricyclic antidepressants, targeted tricyclic antidepressant testing can be used when there is a specific reason to investigate this class of medication. Understanding the distinction between screening and confirmatory analysis is essential when drug-test results need to be interpreted accurately, particularly in forensic and other high-stakes settings.
Frequently Asked Questions
Do antidepressants show up on drug tests?
Most routine drug screens are not designed to detect antidepressants as a drug class. However, certain antidepressants may be associated with unexpected results on particular screening assays.
Can antidepressants show up on a drug test?
It depends on the testing panel and analytical method. Antidepressants are not generally included in many routine drug screens, but some medications may be specifically tested for or may interfere with certain screening assays.
Can antidepressants cause a false positive drug test?
Certain antidepressants have been associated with false-positive or unexpected results on particular screening assays. A presumptive positive does not necessarily establish that the screened drug is present, which is why confirmatory testing may be appropriate.
Do SSRIs show up on drug tests?
SSRIs are generally not the primary target of routine drug screens. However, the potential for unexpected results depends on the individual medication and the specific screening assay.
Do tricyclic antidepressants show up on drug tests?
TCAs can be specifically included in toxicology testing, although they are not necessarily part of every routine drug-screening panel. Testing requirements depend on the purpose of the analysis and the substances being investigated.
What medications show up on a drug test?
A medication will only be detected if it falls within the scope of the testing method being used. A targeted laboratory test may investigate specific medications or metabolites that are not included in a routine drug panel.
Does a positive drug screen always mean drugs were taken?
No. An initial screening result can be presumptive, and certain compounds may interfere with particular screening assays. More specific laboratory testing may be used when definitive identification is required.
